Filing Details

Accession Number:
0001192482-10-000332
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-12-08 08:10:50
Reporting Period:
2010-11-16
Filing Date:
2010-12-08
Accepted Time:
2010-12-08 08:10:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
352998 Igi Laboratories Inc IG Biological Products, (No Disgnostic Substances) (2836) 010355758
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1358088 Nadya Lawrence C/O Igi Laboratories
105 Lincoln Avenue
Buena NJ 08310
Exec. Vp-Sales And Marketing No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-11-16 5,000 $0.50 15,928 No 4 M Direct
Common Stock Disposition 2010-11-16 5,000 $1.60 10,928 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2010-11-16 5,000 $0.00 5,000 $0.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
245,000 2010-12-06 No 4 M Direct
Footnotes
  1. The options vested immediately.